On 12 September New Zealand’s National Cervical Screening Programme will switch to human papillomavirus testing, used in both the UK and Australia. The new screening method, with the option to self-test, will be a game changer in the fight against cervical cancer, writes Jane O’Hallahan
“We are very pleased Pharmac has today announced a Request for Proposal (RFP) for the supply of lenalidomide and pomalidomide to treat multiple myeloma,” says Barbara Horne, Chair of Myeloma New Zealand
Pharmac has missed a golden opportunity to allow more Kiwis access to a new breast cancer drug, a move that would have brought New Zealand into line with the rest of the world and removed a disparity that hits Māori and Pasifika hardest, says Breast Cancer Foundation NZ
Te Pātaka Whaioranga – Pharmac is transitioning to a trastuzumab biosimilar, Herzuma, from the currently funded brand, Herceptin, as a result of a competitive procurement process. The treatment is currently funded for people with metastatic HER2 positive breast cancer
The RNZCGP has accused the National Party of “political gamesmanship” over its plan to slash the number of people receiving free prescriptions to fund new cancer drugs
The Cancer Society of New Zealand has welcomed the announcement by the National Party that, if elected, it will fund 13 vital cancer treatments, but hopes the funding will extend to infrastructure to support the move
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management